Help us: Donate
Follow us on:
×

Menu

Back

Lifespan News – A New Senolytic Enters Human Trials

On Lifespan News this week, Brent Nally discusses skin regeneration, senolytics in human trials, T cell progenitors that boost the effectiveness of stem cell therapies, antibodies for glucosepane, and big pharma attempting to discover more senolytic drugs.

Further Reading

Regenerating Skin With a Single Protein

A New Senolytic Enters Human Trials

T Cell Progenitors Boost Stem Cell Therapy Effectiveness

Creating Anti-Glucosepane Antibodies

Big pharma enters senolytic drug discovery program

Stay in the know

Join our newsletter to enjoy the latest aging research news, special offers for our online and physical events, and more!

CategoryLifeXtenShow, News
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.